No annual revenue total was found in CARTESIAN GROWTH CORPORATION II's SEC filings.
Cartesian Growth Corporation II (RENEF) files with the SEC under industry code 6770, Blank Checks.
Revenue
—
Net income (TTM)
$474,970
-88.0% vs year-ago TTM
Operating cash flow (TTM)
$-780,615
+3.4% vs year-ago TTM
Free cash flow
—
EPS
$0.24
Dividend per share
None
Shares outstanding
—
Net cash
—
Operating margin
—
Company profile
- Industry
- Blank Checks (SIC 6770)
- Listed as
- RENEF (OTC), REEUF (OTC), REEWF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- New York, NY
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1889112
Other Blank Checks companies
- Drugs Made In America Acquisition II Corp. DMII
- EQV Ventures Acquisition Corp. II EVAC
- Bain Capital GSS Investment Corp. BCSS
- Cantor Equity Partners IV, Inc. CEPF
- Churchill Capital Corp XII CXII
- American Exceptionalism Acquisition Corp. A AEXA
- New America Acquisition I Corp. NWAX
- Ares Acquisition Corp III AAC
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| Operating income | -$931,461 | -$1.0M | -$2.0M | -$685,056 |
| Net income | -$1.5M | $8.2M | $11.4M | $4.9M |
| Diluted EPS | — | — | — | $0.24 |
| Operating cash flow | -$773,847 | -$814,232 | -$922,735 | -$842,878 |
| Total assets | $38.3M | $85.0M | $174.6M | $240.6M |
| Total liabilities | $26.7M | $20.7M | $18.9M | $18.9M |
| Stockholders' equity | -$26.3M | -$20.3M | -$18.5M | -$18.0M |
| Cash and investments | $38.1M | $84.8M | $174.3M | $240.3M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, New debt
|
Oct 14, 2026 | Oct 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 14, 2026 | Aug 14, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Aug 4, 2026 | Jul 30, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jul 27, 2026 | Jul 24, 2026 |
| 8-K |
Current report
Other events
|
Jul 24, 2026 | Jul 24, 2026 |
All 148 Cartesian Growth Corporation II SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.